Background: Cranioplasty is a common neurosurgical procedure and autologous grafts are preferred due to their aesthetic and biocompatibility benefits. Multiple risk factors are implicated as predictors for neurologic outcome. This study focuses on risk factors that may be associated with complications and analyzes the predictors of neurologic outcomes after autologous cranioplasty. Methods: This is a retrospective observational study conducted at a tertiary care center between 2015 and 2021. Adults with autologous cranioplasty (n = 132) were recruited from procedure logs and the hospital electronic health record. Clinicodemographic parameters, risk factors, and complications were recorded. Neurologic outcomes were measured using the dichotomized Glasgow Outcome Scale (GOS). Primary outcome measure was pre- and post-cranioplasty GOS at the last follow up. Secondary outcome measures were the predicting factors that contributed to enhanced neurologic outcome post-cranioplasty. Results: Mean age was 41.4 (standard deviation ± 13.5) years with male predominance (12.2:1). Complications developed in 12.9% (n = 17), with infections in 3.8% (n = 5) and hydrocephalus in 2.3% (n = 3). In bivariate analysis, pre-cranioplasty GOS good grades 4 and 5 (P < 0.001), trauma as an indication for decompressive craniectomy (DC) (P < 0.001), and early cranioplasty ≤12 weeks (P = 0.023) were statistically significant predictors for post-cranioplasty neurologic recovery at follow-up. In a multiple logistic regression model, adjusted odds ratio for pre-cranioplasty GOS was 28.77 (95% confidence interval [CI] 7.21-114.74, P < 0.001), for trauma as indication for DC was 5.15 (95% CI 1.65-16.05, P = 0.003), and for early cranioplasty ≤12 weeks was 3.04 (95% CI 1.12-8.27 P = 0.029). Conclusions: Autologous cranioplasty contributes to a quantifiable neurologic outcome. Pre-cranioplasty neurologic status, cranioplasty done for traumatic DC and early cranioplasty may have potential for enhanced neurologic recovery. Further clinical studies with better evidence may expound upon these findings.

Autologous; Clinical outcome; Cranioplasty; Neurologic; Predictors; Prognosis

Saleh Safi 1, Arshad Ali 2, Ibrahim Abdelhafez 3, Abdul Salam 4, Talal Alrabayah 5, Abdulnasser Alyafei 6, Sirajeddin Belkhair 2

1.Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar. Electronic address: sal7.sfi@gmail.com. 2.Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar; Department of Clinical Academic Sciences, College of Medicine, Qatar University, Doha, Qatar; Department of Neurological Sciences, Weill Cornell Medicine, Doha, Qatar. 3.Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar. 4.Department of Epidemiology and Biostatistics, King Fahad Specialist Hospital, Dammam, Kingdom of Saudi Arabia. 5.Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar; Department of Clinical Academic Sciences, College of Medicine, Qatar University, Doha, Qatar. 6.Department of Neurosurgery, Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar; Department of Neurological Sciences, Weill Cornell Medicine, Doha, Qatar.

World Neurosurg

/

2022

自体颅骨

35977678

10.1016/j.wneu.2022.08.043